Evidence map›Paper›PMID 33054516›Full record

ReviewSmall GTPases

Pathophysiological functions of Rnd proteins.

Sara Basbous, Roberta Azzarelli, Emilie Pacary, Violaine Moreau

Open access · greenAbstract readReview
In one paragraph

Review in Small GTPases. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
2.3field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 36 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Structural Dynamics of Rho GTPases.Journal of molecular biology · 2025
    Review
  8. Article
  9. Article
  10. Review
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Effect of RhoE expression on the migration and invasion of tongue squamous cell carcinoma.Hua xi kou qiang yi xue za zhi = Huaxi kouqiang yixue zazhi = West China journal of stomatology · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 2 countries.

Sara BasbousINSERM, BaRITOn, U1053, F-33000, Univ. Bordeaux, Bordeaux, France.
Roberta AzzarelliDepartment of Biology, Unit of Cell and Developmental Biology, University of Pisa, Pisa, Italy.
Emilie PacaryINSERM, U1215 - Neurocentre Magendie, F-33077, Univ. Bordeaux, Bordeaux, France.
Violaine MoreauINSERM, BaRITOn, U1053, F-33000, Univ. Bordeaux, Bordeaux, France.
Bordeaux Population Health · FRInserm · FRUniversity of Pisa · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Rnd proteins constitute a subfamily of Rho GTPases represented in mammals by Rnd1, Rnd2 and Rnd3. Despite their GTPase structure, their specific feature is the inability to hydrolyse GTP-bound nucleotide. This aspect makes them atypical among Rho GTPases. Rnds are regulated for their expression at the transcriptional or post-transcriptional levels and they are activated through post-translational modifications and interactions with other proteins. Rnd proteins are mainly involved in the regulation of the actin cytoskeleton and cell proliferation. Whereas Rnd3 is ubiquitously expressed, Rnd1 and 2 are tissue-specific. Increasing data has described their important role during development and diseases. Herein, we describe their involvement in physiological and pathological conditions with a focus on the neuronal and vascular systems, and summarize their implications in tumorigenesis.

Indexed as

HumansNeoplasmsNervous System Diseasesrho GTP-Binding ProteinsVascular Diseasesrho GTP-Binding ProteinsRND1 protein, humanRND2 protein, humanRND3 protein, humancancerneuronal systempathophysiologyRndvascular system

Identifiers

PMID33054516
PMCPMC8583191
OpenAlexW3093250434

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.